Because the vestibular system is influenced by hormonal changes during menopause, this effect could potentially contribute to the emergence of vertigo symptoms during this stage of women’s lives.

Dependency relationships were found between the prevalence of depression and physical activity level, anxiety and physical activity level, and self-perceived health with physical activity level.

Regularly screening for osteoarthritis should be implemented for menopausal women with diabetes mellitus and utmost care should be provided by healthcare professionals.

Modeling results showed square dance exercises could positively predict positive affect through the chain-mediating effect of psychological resilience and life satisfaction among menopausal women.

Study researchers explored the relative contribution of estrogen levels and spinal-related musculoskeletal variables of kyphosis, lordosis, back muscle strength, and endurance to gait speed in 135 health middle-aged women from urban health centers and entertainment districts.

People who identify as nonbinary as well as those who are sexual minorities experienced challenges locating inclusive menopause resources and culturally competent clinicians who created safe, trusting healthcare environments.

Menopause-related symptoms such as vasomotor symptoms, sleep disturbances, and mood changes may all have a direct impact on CVD risk.

Greater proportions of fezolinetant-treated versus placebo-treated participants had ≥50%, ≥75%, ≥90%, or 100% reduction in vasomotor symptom frequency from baseline to weeks 4 and 12.

Exposure to specific pollutants may promote premature menopause and vasomotor symptoms, elevate the risk of CVD, and reduce bone density.

Replacing 1 hour of sitting with 1 hour of vigorous activity was associated with a 100% increase in subjectively reported but not objectively measured waking hot flashes.

Hair loss may occur in the case of estrogen deficiency, appearing naturally during menopause.

Efficacy was most notable for participants who self-identify as Black, current smokers, and current alcohol users.

At least 50% reductions were noticed in the frequency of vasomotor symptoms as well as the degree of bother/interference of vasomotor symptoms at 6 months.

Hormone replacement therapy was associated with increased GI symptoms, including early satiety, domperidone use, and undergoing gastric emptying studies.

Across women, greater aggregate exposure to neighborhood poverty in adulthood was related to lower ovarian reserve, indexed by antimüllerian hormone.

Estrogen replacement therapy did not significantly change the risk of first hospital stay for heart failure and admission to the hospital for heart failure in postmenopausal women.

Because of the high-quality evidence supporting the efficacy of fezolinetant and elinzanetant, these agents may be an effective option with mild adverse events for women seeking nonhormone treatment of vasomotor symptoms.

The severity of menopausal symptoms was found to significantly predict more emotional exhaustion, less work engagement, and greater turnover intentions.

The unadjusted accelerated failure time survival model revealed a significant positive association between polycystic ovary syndrome (PCOS) and age at natural menopause; women with PCOS experienced time to menopause by a factor of 1.05 than non-PCOS controls.

Overall, the results provided evidence of acceptable psychometric properties of the Menopause-Specific Quality of Life overall and domain scores using 1-week recall.